These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24998289)

  • 1. Targeting the inhibitor of Apoptosis Protein BIR3 binding domains.
    Jaquith JB
    Pharm Pat Anal; 2014 May; 3(3):297-312. PubMed ID: 24998289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies.
    Smolewski P; Robak T
    Curr Mol Med; 2011 Nov; 11(8):633-49. PubMed ID: 21902653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
    Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
    ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
    Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
    FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of apoptotic proteins: new targets for anticancer therapy.
    Saleem M; Qadir MI; Perveen N; Ahmad B; Saleem U; Irshad T; Ahmad B
    Chem Biol Drug Des; 2013 Sep; 82(3):243-51. PubMed ID: 23790005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of Smac-mimetic compounds by the BIR domain of cIAP1.
    Cossu F; Malvezzi F; Canevari G; Mastrangelo E; Lecis D; Delia D; Seneci P; Scolastico C; Bolognesi M; Milani M
    Protein Sci; 2010 Dec; 19(12):2418-29. PubMed ID: 20954235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2.
    Cossu F; Mastrangelo E; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Seneci P; Scolastico C; Bolognesi M
    Biochem Biophys Res Commun; 2009 Jan; 378(2):162-7. PubMed ID: 18992220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzazepinones and benzoxazepinones as antagonists of inhibitor of apoptosis proteins (IAPs) selective for the second baculovirus IAP repeat (BIR2) domain.
    Donnell AF; Michoud C; Rupert KC; Han X; Aguilar D; Frank KB; Fretland AJ; Gao L; Goggin B; Hogg JH; Hong K; Janson CA; Kester RF; Kong N; Le K; Li S; Liang W; Lombardo LJ; Lou Y; Lukacs CM; Mischke S; Moliterni JA; Polonskaia A; Schutt AD; Solis DS; Specian A; Taylor RT; Weisel M; Remiszewski SW
    J Med Chem; 2013 Oct; 56(20):7772-87. PubMed ID: 24083782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.
    Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M
    J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domain.
    Kester RF; Donnell AF; Lou Y; Remiszewski SW; Lombardo LJ; Chen S; Le NT; Lo J; Moliterni JA; Han X; Hogg JH; Liang W; Michoud C; Rupert KC; Mischke S; Le K; Weisel M; Janson CA; Lukacs CM; Fretland AJ; Hong K; Polonskaia A; Gao L; Li S; Solis DS; Aguilar D; Tardell C; Dvorozniak M; Tannu S; Lee EC; Schutt AD; Goggin B
    J Med Chem; 2013 Oct; 56(20):7788-803. PubMed ID: 24093940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of immune signalling by inhibitors of apoptosis.
    Beug ST; Cheung HH; LaCasse EC; Korneluk RG
    Trends Immunol; 2012 Nov; 33(11):535-45. PubMed ID: 22836014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R
    J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of the inhibitor of apoptosis protein (IAP) family in hematological malignancies].
    Grzybowska-Izydorczyk O; Smolewski P
    Postepy Hig Med Dosw (Online); 2008 Feb; 62():55-63. PubMed ID: 18283236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting inhibitor of apoptosis proteins (IAPs) with IAP inhibitors sensitises malignant rhabdoid tumour cells to cisplatin.
    Coyle R; O'Sullivan MJ; Zisterer DM
    Cancer Treat Res Commun; 2022; 32():100579. PubMed ID: 35613525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Dynamics simulations of Inhibitor of Apoptosis Proteins and identification of potential small molecule inhibitors.
    Jayakumar J; Anishetty S
    Bioorg Med Chem Lett; 2014 May; 24(9):2098-104. PubMed ID: 24717152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of apoptosis catch ubiquitin.
    Rajalingam K; Dikic I
    Biochem J; 2009 Jan; 417(1):e1-3. PubMed ID: 19061481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF023 binding to XIAP-BIR1: searching drugs for regulation of the NF-κB pathway.
    Cossu F; Milani M; Grassi S; Malvezzi F; Corti A; Bolognesi M; Mastrangelo E
    Proteins; 2015 Apr; 83(4):612-20. PubMed ID: 25619915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1).
    Blankenship JW; Varfolomeev E; Goncharov T; Fedorova AV; Kirkpatrick DS; Izrael-Tomasevic A; Phu L; Arnott D; Aghajan M; Zobel K; Bazan JF; Fairbrother WJ; Deshayes K; Vucic D
    Biochem J; 2009 Jan; 417(1):149-60. PubMed ID: 18939944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different Degradation Mechanisms of Inhibitor of Apoptosis Proteins (IAPs) by the Specific and Nongenetic IAP-Dependent Protein Eraser (SNIPER).
    Ohoka N; Ujikawa O; Shimokawa K; Sameshima T; Shibata N; Hattori T; Nara H; Cho N; Naito M
    Chem Pharm Bull (Tokyo); 2019 Mar; 67(3):203-209. PubMed ID: 30369550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine Covalent Antagonists of Melanoma Inhibitors of Apoptosis Protein.
    Udompholkul P; Baggio C; Gambini L; Alboreggia G; Pellecchia M
    J Med Chem; 2021 Nov; 64(21):16147-16158. PubMed ID: 34705456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.